BMP4-overexpressing ALL cells also have the ability to generate MØs with a more marked M2-like phenotype and enhanced pro-tumoral features evidenced by a lower TNF-α/IL-10 expression ratio and upregulated expression levels of CCL2 and IL-6. This evidence concerns the gene CCL2 and acute lymphoblastic leukemia.